Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RETK666N Germline Pathogenic Variant

By sjmartinez • February 18, 2025

Yip AT, Kim TH, Peluso EM, Jacobsen SE, Yeh MW, Lechner MG. Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant. JCEM Case Rep. 2025 Feb 17;3(3):luaf002. doi: 10.1210/jcemcr/luaf002. PMID: 39963300; PMCID: PMC11831074.

Tags: Endocrinology, germline, medullary thyroid carcinoma, MEN2, pathogenic variant, Publications, RET K666N

Colliding crises: The global diabetes pandemic meets climate change-A scoping review

Perez JS, Hudson H, Araneta J, Bedell B, Aikins AD, Dugas LR, Eid M, Eshac Y, Fariduddin M, Fariduddin M, Jong K, Kapwata T, Luke[...]

Glymphatic system impairment in type II diabetes mellitus adults

Roy B, Lubera V, Singh KR, Singh A, Karunamuni DR, Kosoyan DE, Carrier M, Choi SE, Freeby MJ, Kumar R. Glymphatic system impairment in type[...]

Osilodrostat for Cyclic Cushing Disease

Rhyu J, Yu R. Osilodrostat for Cyclic Cushing Disease. AACE Endocrinol Diabetes. 2025 Sep 30;13(1):17-21. doi: 10.1016/j.aed.2025.09.011. PMID: 41641307; PMCID: PMC12866165.